Assessment of Retinal Fundus Imaging Camera

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The goal of this prospective study is to evaluate device performance when using fundus images taken from retinal fundus cameras in subjects with and without diabetic retinopathy per ETDRS level 35 and higher with or without macular edema.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:

• 22 years of age or older.

• Documented diagnosis of diabetes mellitus, as per any of the following: Having met the criteria established by the World Health Organization (WHO) and/or the American Diabetes Association (ADA), Hemoglobin A1c (HbA1c) ≥ 6.5%, Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L), Oral Glucose Tolerance Test (OGTT) with two-hour plasma glucose (2-hr PG) ≥ 200 mg/dL (11.1 mmol/L), using the equivalent of an oral 75g anhydrous glucose dose dissolved in water, Symptoms of hyperglycemia or hyperglycemic crisis with a random plasma glucose (RPG) ≥ 200 mg/dL (11.1 mmol/L)

• Ability to understand and the willingness to sign a written informed consent document.

• Diagnosis from a retinal specialist of ETDRS level of 35 or higher with or without DME or diagnosis from a retinal specialist of ETDRS level 20 or lower and no DME.

• Standard Corrected Visual Acuity of at least 20/40 or better in both eyes.

Locations
United States
Ohio
Midwest Eye Center
RECRUITING
Cincinnati
Contact Information
Primary
Breanne MacMillan, MS
macmillan@digitaldiagnostics.com
815-931-1354
Time Frame
Start Date: 2023-11-20
Estimated Completion Date: 2024-05
Participants
Target number of participants: 100
Treatments
Group 1
Subjects with ETDRS ≥ 35 with or without DME
Group 2
Subjects with ETDRS 20 or less and no DME
Sponsors
Leads: Digital Diagnostics, Inc.

This content was sourced from clinicaltrials.gov